Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Philippe Brouqui and Jean-Christophe Lagier.
Philippe Brouqui
Connection Strength
3.162
Jean-Christophe Lagier
  1. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624.
    View in: PubMed
    Score: 0.872
  2. COVID-19 re-infection. Eur J Clin Invest. 2021 May; 51(5):e13537.
    View in: PubMed
    Score: 0.234
  3. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2021 Jan; 102:233-238.
    View in: PubMed
    Score: 0.228
  4. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791.
    View in: PubMed
    Score: 0.222
  5. West Nile virus outbreak in the South of France: Implications for travel medicine. Travel Med Infect Dis. 2019 Mar - Apr; 28:100-101.
    View in: PubMed
    Score: 0.201
  6. Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities. Int J Antimicrob Agents. 2019 Apr; 53(4):355-361.
    View in: PubMed
    Score: 0.199
  7. From Expert Protocols to Standardized Management of Infectious Diseases. Clin Infect Dis. 2017 Aug 15; 65(suppl_1):S12-S19.
    View in: PubMed
    Score: 0.182
  8. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732.
    View in: PubMed
    Score: 0.059
  9. Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2021 Feb 16; 12(1):21.
    View in: PubMed
    Score: 0.058
  10. Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients? J Microbiol Immunol Infect. 2021 Oct; 54(5):997-1000.
    View in: PubMed
    Score: 0.058
  11. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184.
    View in: PubMed
    Score: 0.058
  12. Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2020 Nov 17; 11(1):117.
    View in: PubMed
    Score: 0.057
  13. Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371.
    View in: PubMed
    Score: 0.057
  14. Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score. PLoS One. 2020; 15(11):e0241407.
    View in: PubMed
    Score: 0.057
  15. Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis. 2020 Sep - Oct; 37:101875.
    View in: PubMed
    Score: 0.056
  16. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987.
    View in: PubMed
    Score: 0.056
  17. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect. 2020 Nov; 38:100709.
    View in: PubMed
    Score: 0.055
  18. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.055
  19. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663.
    View in: PubMed
    Score: 0.055
  20. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949.
    View in: PubMed
    Score: 0.055
  21. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632.
    View in: PubMed
    Score: 0.055
  22. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 04; 55(4):105932.
    View in: PubMed
    Score: 0.054
  23. Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 02; 25(8).
    View in: PubMed
    Score: 0.054
  24. Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections. Clin Infect Dis. 2018 02 10; 66(5):645-650.
    View in: PubMed
    Score: 0.047
  25. Infections in symptomatic travelers returning from the Arabian peninsula to France: A retrospective cross-sectional study. Travel Med Infect Dis. 2016 Jul-Aug; 14(4):414-6.
    View in: PubMed
    Score: 0.042
  26. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014 Apr; 20(4):728-30.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.